A Study of Ivonescimab in People With Leiomyosarcoma
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT07516925
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Leiomyosarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ivonescimab — DRUGIvonescimab is administered IV Q3W on Day 1 of each cycle
Study Details
The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unresectable leiomyosarcoma.
Key Dates
- Start date
- Apr 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: IvonescimabIvonescimab is administered IV Q3W on Day 1 of each cycle. The total duration of ivonescimab treatment is up to 24 months.
Primary Outcome Measure
Response [ Time Frame: up to two years ]
Central Contacts
- Sandra D'Angelo, MD646-888-4159zzPDL_MED_Sarcoma_Clinical_Trials <[email protected]>
- Sujana Movva, MD646-888-6787
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Commack | New York | 11725 | |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Sujana Movva, MD 646-888-6787 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Rockville Centre | New York | 11553 |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)PHASE3 · Recruiting · Advenchen Laboratories, LLC · Phoenix, Arizona
- Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPHASE3 · Recruiting · European Organisation for Research and Treatment of Cancer - EORTC · Birmingham, Alabama
- Metastatic Leiomyosarcoma Biomarker ProtocolRecruiting · University of Michigan Rogel Cancer Center · Santa Monica, California
- STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasPHASE1/PHASE2 · Recruiting · STORM Therapeutics LTD · Lake Success, New York